Cargando…

Pseudogene TNXA Variants May Interfere with the Genetic Testing of CAH-X

CAH-X is a hypermobility-type Ehlers–Danlos syndrome connective tissue dysplasia affecting approximately 15% of patients with 21-hydroxylase deficiency (21-OHD) congenital adrenal hyperplasia (CAH) due to contiguous deletion of CYP21A2 and TNXB genes. The two most common genetic causes of CAH-X are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lao, Qizong, Zhou, Kiet, Parker, Megan, Faucz, Fabio R., Merke, Deborah P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9956258/ https://www.ncbi.nlm.nih.gov/pubmed/36833192 http://dx.doi.org/10.3390/genes14020265

Ejemplares similares

Molecular genetic testing of congenital adrenal hyperplasia due to 21-hydroxylase deficiency should include CAH-X chimeras
por: Lao, Qizong, et al.
Publicado: (2021)

Measurement of serum tenascin-X in patients with congenital adrenal hyperplasia at risk for Ehlers–Danlos contiguous gene deletion syndrome CAH-X
por: Kolli, Vipula, et al.
Publicado: (2019)

Congenital adrenal hyperplasia due to two rare CYP21A2 variant alleles, including a novel attenuated CYP21A1P/CYP21A2 chimera
por: Lao, Qizong, et al.
Publicado: (2023)

A TNXB splice donor site variant as a cause of hypermobility type Ehlers–Danlos syndrome in patients with congenital adrenal hyperplasia
por: Lao, Qizong, et al.
Publicado: (2020)

Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene
por: Fanis, Pavlos, et al.
Publicado: (2022)

SAT-069 A Case of Congenital Hypoaldosteronism Due to Aldosterone Synthase Deficiency Misdiagnosed as Classic Congenital Adrenal Hyperplasia
por: Mallappa, Ashwini, et al.
Publicado: (2019)

SAT288 Development Of CAH-specific Patient Reported Outcome (PRO) Instrument To Assess Health-related Quality Of Life (HRQoL)
por: Flokas, Myrto Eleni, et al.
Publicado: (2023)

Unusual Combination of MEN-1 and the Contiguous Gene Deletion Syndrome of CAH and Ehlers-Danlos Syndrome (CAH-X)
por: Chen Cardenas, Stanley M, et al.
Publicado: (2020)

Prevalence of CAH-X Syndrome in Italian Patients with Congenital Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency
por: Paragliola, Rosa Maria, et al.
Publicado: (2022)

The human ABC transporter pseudogene family: Evidence for transcription and gene-pseudogene interference
por: Piehler, Armin P, et al.
Publicado: (2008)

Diagnosis and prevalence of Congenital Adrenal Hyperplasia (CAH) in Austrian children screened or not screened for CAH
por: Luxenberger, Katharina, et al.
Publicado: (2013)

Manuscrito de Chan Cah.
Publicado: (1982)

Molecular basis and genetic testing strategies for diagnosing 21-hydroxylase deficiency, including CAH-X syndrome
por: Kim, Ja Hye, et al.
Publicado: (2023)

Tildacerfont for the Treatment of Patients With Classic Congenital Adrenal Hyperplasia: Results From a 12-Week Phase 2 Clinical Trial in Adults With Classic CAH
por: Auchus, Richard Joseph, et al.
Publicado: (2021)

Diagnosis and management of rare forms of CAH
por: Sahakitrungruang, Taninee
Publicado: (2015)

Should CAH in Females Be Classified as DSD?
por: González, Ricardo, et al.
Publicado: (2016)

Newborn Screening for CAH—Challenges and Opportunities
por: Heather, Natasha L., et al.
Publicado: (2021)

Misaligned sequencing reads from the GNAQ-pseudogene locus may yield GNAQ artefact variants
por: Lim, Jing Quan, et al.
Publicado: (2022)

CAH Newborn Screening in India: Challenges and Opportunities
por: Dabas, Aashima, et al.
Publicado: (2020)

MON-177 CAH-X Syndrome in a German Cohort of Patients with Congenital Adrenal Hyperplasia
por: Sappl, Andrea, et al.
Publicado: (2020)

RF09 | PSAT70 Comparison of Prednisolone Versus Modified-release Hydrocortisone (Efmody) in the Treatment of Congenital Adrenal Hyperplasia (CAH)
por: Merke, Deborah P, et al.
Publicado: (2022)

SAT326 Massive Adrenomyelolipomas Due To Longstanding CAH
por: Aziz, Qurrat-ul-ain, et al.
Publicado: (2023)

Pseudogenes
por: Tutar, Yusuf
Publicado: (2012)

Accelerated pseudogenization on the neo-X chromosome in Drosophila miranda
por: Nozawa, Masafumi, et al.
Publicado: (2016)

UBB pseudogene 4 encodes functional ubiquitin variants
por: Dubois, Marie-Line, et al.
Publicado: (2020)

Should the Genitoplasty of Girls with CAH be Done in One or Two Stages?
por: González, Ricardo, et al.
Publicado: (2014)

OR24-06 USP8 Genetic Variants May Contribute to the Development of Bilateral Adrenal Hyperplasia and ACTH-Independent Cushing Syndrome
por: Settas, Nikolaos, et al.
Publicado: (2020)

SUN-167 Treatment Considerations for a Healthy Pregnancy in Women with Classical Congenital Adrenal Hyperplasia (CAH)
por: Calzia, Megan, et al.
Publicado: (2020)

Evaluation of parental knowledge after establishing CAH clubs in Vietnam & Indonesia
por: Mitchelhill, Irene, et al.
Publicado: (2015)

Case Report of an Adult Female with Neglected Congenital Adrenal Hyperplasia (CAH)
por: Krishnan, Gayathri Devi, et al.
Publicado: (2018)

Desiccation-induced fibrous condensation of CAHS protein from an anhydrobiotic tardigrade
por: Yagi-Utsumi, Maho, et al.
Publicado: (2021)

The etiology and clinical features of non-CAH primary adrenal insufficiency in children
por: Liu, Ziqin, et al.
Publicado: (2022)

Trehalose and tardigrade CAHS proteins work synergistically to promote desiccation tolerance
por: Nguyen, Kenny, et al.
Publicado: (2022)

FRI245 Non-classic CAH Presenting As Bilateral Adrenal Incidentalomas
por: Chin, Yun Ann, et al.
Publicado: (2023)

Pseudogene.org: a comprehensive database and comparison platform for pseudogene annotation
por: Karro, John E., et al.
Publicado: (2007)

SAT304 Improved Biochemical Control With Dose Reduction In Chronic Glucocorticoid Therapy: A Phase III Extension Study Of Chronocort (Efmody) In The Treatment Of Congenital Adrenal Hyperplasia (CAH)
por: Ross, Richard John M, et al.
Publicado: (2023)

The GENCODE pseudogene resource
por: Pei, Baikang, et al.
Publicado: (2012)

Pseudogenes in Human Cancer
por: Poliseno, Laura, et al.
Publicado: (2015)

Role of Pseudogenes in Tumorigenesis
por: Hu, Xinling, et al.
Publicado: (2018)

Pseudogenes in Cardiovascular Disease
por: Qi, Yanyan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ug5rhi0h87rbqnabcoerl4fpeh